KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 69 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $241,000 | +63.9% | 19,947 | +3.6% | 0.01% | +16.7% |
| Q1 2020 | $147,000 | -58.7% | 19,261 | -3.7% | 0.01% | 0.0% |
| Q4 2019 | $356,000 | -43.1% | 20,000 | -63.0% | 0.01% | -53.8% |
| Q3 2019 | $626,000 | -47.7% | 54,000 | 0.0% | 0.01% | -59.4% |
| Q2 2019 | $1,196,000 | -22.6% | 54,000 | 0.0% | 0.03% | -15.8% |
| Q1 2019 | $1,545,000 | +90.7% | 54,000 | +31.7% | 0.04% | +11.8% |
| Q4 2018 | $810,000 | -8.4% | 41,000 | +2.5% | 0.03% | +47.8% |
| Q3 2018 | $884,000 | – | 40,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |